Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.30 |
| ▸ | FER | P16591 | 1/20 | 0.30 |
| ▸ | LTK | P29376 | 1/20 | 0.30 |
| ▸ | CDK8 | P49336 | 1/20 | 0.30 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.30 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3536526 | 0.76 | NISCH (0.33) | GAAMAPTPDGFRALTKACVR1 | |
| SCHEMBL28780480 | 0.73 | PDK2 (0.38) | — | |
| SCHEMBL752653 | 0.68 | GRK6 (0.37) | GAAMAPT | |
| SCHEMBL31154216 | 0.67 | GAA (0.32) | GAAMAPT | |
| SCHEMBL5325946 | 0.67 | MAPT (0.41) | GAAMAPTMAOAMAOBPDGFRA | |
| SCHEMBL8102711 | 0.67 | MAPT (0.41) | GAAMAPT | |
| SCHEMBL31390287 | 0.66 | — | — | |
| Hydrochloric Acid SCHEMBL4483575 | 0.65 | GAA (0.31) | GAAMAPTNOS2 | |
| SCHEMBL5604886 | 0.65 | GAA (0.34) | GAAMAPT | |
| SCHEMBL3501047 | 0.65 | POLB (0.31) | MAPTDYRK1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | FREISTAAT BAYERN LUDWIG MAXIMILIANS UNIV MUENCHEN (DE) | 2025-12-11 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250120980-A1 | DIBENZODIAZEPINE COMPOUNDS AND USE IN INTERFERON ACTIVATOR PROTEIN AGONISTS THEREOF | HEBEI GRANDIOS PHARMA CO, LTD. (CN) | 2025-04-17 | — | — | US | claimed |
| CN-116987040-A | Dibenzodiazepine derivative and preparation method and application thereof | 中国中医科学院中药研究所 | 2023-11-03 | — | — | CN | claimed |
| CN-116854643-A | Synthesis method of dibenzodiazepine or oxyazepine compound | 中山大学 | 2023-10-10 | — | — | CN | claimed |
| CN-114349714-B | Dibenzodiazepine derivative and preparation method and application thereof | 华中师范大学 | 2023-09-29 | — | — | CN | claimed |
| CN-114349714-A | Dibenzodiazepine derivative and preparation method and application thereof | 华中师范大学 | 2022-04-15 | — | — | CN | claimed |
| EP-3812373-A1 | NOVEL COMPOUND BINDING TO DESIGNER RECEPTOR, IMAGING METHOD FOR DESIGNER RECEPTOR, AGONIST OR ANTAGONIST, THERAPEUTIC AGENT, COMPANION DIAGNOSTIC AGENT, AND IMAGING METHOD FOR NERVE CELL | NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) | 2021-04-28 | — | — | EP | claimed |
| US-20190125825-A1 | SMALL-MOLECULE ADJUVANTS FOR ANTIBIOTICS TO ADDRESS ANTIBIOTIC RESISTANCE | HIGH POINT UNIVERSITY | 2019-05-02 | — | — | US | claimed |
| US-9974839-B2 | Self-assembled toroidal-spiral particles and manufacture and uses thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-05-22 | — | — | US | claimed |
| US-4938758-A | Anti-pathogenic blood collection system and method | AL SIOUFI HABIB (US) | 1990-07-03 | — | — | US | claimed |
| EP-0263873-A4 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD. | AL-SIOUFI HABIB | 1989-07-11 | — | — | EP | claimed |
| EP-0263873-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL-SIOUFI, Habib (US) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006119-A1 | ANTI-PATHOGENIC BLOOD COLLECTION SYSTEM AND METHOD | AL SIOUFI HABIB | 1987-10-22 | — | — | WO | claimed |
| US-4654323-A | BLOCKING AGENT FOR CALCIUM CALMODULIN COMPLEX | BAR ILAN UNIVERSITY (IL) | 1987-03-31 | — | — | US | claimed |
| EP-0168626-A1 | Composition for the manufacture of a medicament for the therapeutic treatment of trauma of the skin | BAR-ILAN UNIVERSITY (IL) | 1986-01-22 | — | — | EP | claimed |
| EP-0085892-B1 | SUBSTITUTED BENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1985-12-18 | — | — | EP | claimed |
| US-4377577-A | Use of psychoactive drugs in uterus to prevent pregnancy | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1983-03-22 | — | — | US | claimed |
| EP-0053108-A1 | VAGINAL CONTRACEPTIVES COMPRISING PSYCHOACTIVE DRUGS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1982-06-09 | — | — | EP | claimed |
| WO-1981003421-A1 | USE OF PSYCHOACTIVE DRUGS AS VAGINAL CONTRACEPTIVES | UNIV GEORGIA (US) | 1981-12-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190125825-A1 | SMALL-MOLECULE ADJUVANTS FOR ANTIBIOTICS TO ADDRESS ANTIBIOTIC RESISTANCE | MYD88, TLR5, TLR3 | GAA 3627/4885MAPT 4861/4885NOS2 3565/4885 |
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CRY1, MKI67, IK | GAA 3939/4885MAPT 1613/4885NOS2 312/4885 |
| US-20250120980-A1 | DIBENZODIAZEPINE COMPOUNDS AND USE IN INTERFERON ACTIVATOR PROTEIN AGONISTS THEREOF | STING1, IRF3, IFNAR1 | GAA 1045/4885MAPT 3812/4885NOS2 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.